www.fdanews.com/articles/197429-uk-researchers-test-ibuprofen-to-treat-covid-19-complication
![UKflag.jpg](https://www.fdanews.com/ext/resources/test/Drug-Images4/UKflag.jpg?t=1586293848&width=430)
UK Researchers Test Ibuprofen to Treat COVID-19 Complication
June 4, 2020
Researchers in the United Kingdom are launching a clinical trial to test a unique formulation of ibuprofen for treatment of severe acute respiratory distress syndrome (ARDS) in COVID-19 patients.
Laboratory-based experiments have shown the formulation to be more effective than standard ibuprofen for treating the syndrome.
The London study will recruit hospitalized COVID-19 patients who will either receive the standard of care or ibuprofen in addition to standard of care.